Life Sciences Partners

Summary

The venture was found in Europe in The Netherlands. The main office of represented VC is situated in the Amsterdam.

The fund was created by Clemens Van Blitterswijk, Rudy Dekeyser. The overall number of key employees were 10.

Opposing the other organizations, this Life Sciences Partners works on 4 percentage points more the average amount of lead investments. The top activity for fund was in 2007. Despite it in 2019 the fund had an activity. Speaking about the real fund results, this VC is 18 percentage points more often commits exit comparing to other organizations. The fund is generally included in 2-6 deals every year. The usual things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2014.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Life Sciences Partners, startups are often financed by Kurma Partners, Idinvest Partners, VI Partners AG. The meaningful sponsors for the fund in investment in the same round are Ysios Capital, Idinvest Partners, Johnson & Johnson Development Corporation. In the next rounds fund is usually obtained by Novartis Venture Fund, LSP BioVentures, Gimv.

For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has specific favorite in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. We can highlight the next thriving fund investment areas, such as Therapeutics, Biopharma. Among the various public portfolio startups of the fund, we may underline Santarus, Hyperion Therapeutics, Merus Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.